191 related articles for article (PubMed ID: 32233118)
1. R-spondin-mediated WNT signaling potentiation in mammary and breast cancer development.
Tocci JM; Felcher CM; García Solá ME; Kordon EC
IUBMB Life; 2020 Aug; 72(8):1546-1559. PubMed ID: 32233118
[TBL] [Abstract][Full Text] [Related]
2. R-spondins can potentiate WNT signaling without LGRs.
Lebensohn AM; Rohatgi R
Elife; 2018 Feb; 7():. PubMed ID: 29405118
[TBL] [Abstract][Full Text] [Related]
3. R-Spondins 2 and 3 Are Overexpressed in a Subset of Human Colon and Breast Cancers.
Conboy CB; Vélez-Reyes GL; Rathe SK; Abrahante JE; Temiz NA; Burns MB; Harris RS; Starr TK; Largaespada DA
DNA Cell Biol; 2021 Jan; 40(1):70-79. PubMed ID: 33320737
[TBL] [Abstract][Full Text] [Related]
4. Differential activities and mechanisms of the four R-spondins in potentiating Wnt/β-catenin signaling.
Park S; Cui J; Yu W; Wu L; Carmon KS; Liu QJ
J Biol Chem; 2018 Jun; 293(25):9759-9769. PubMed ID: 29752411
[TBL] [Abstract][Full Text] [Related]
5. Surrogate R-spondins for tissue-specific potentiation of Wnt Signaling.
Luca VC; Miao Y; Li X; Hollander MJ; Kuo CJ; Garcia KC
PLoS One; 2020; 15(1):e0226928. PubMed ID: 31914456
[TBL] [Abstract][Full Text] [Related]
6. Reconstitution of R-spondin:LGR4:ZNRF3 adult stem cell growth factor signaling complexes with recombinant proteins produced in Escherichia coli.
Moad HE; Pioszak AA
Biochemistry; 2013 Oct; 52(41):7295-304. PubMed ID: 24050775
[TBL] [Abstract][Full Text] [Related]
7. Expression of R-spondins/Lgrs in development of movable craniofacial organs.
Nihara J; Kawasaki M; Kawasaki K; Yamada A; Meguro F; Kudo T; Trakanant S; Nagai T; Saito I; Maeda T; Ohazama A
Gene Expr Patterns; 2021 Sep; 41():119195. PubMed ID: 34126267
[TBL] [Abstract][Full Text] [Related]
8. R-spondins engage heparan sulfate proteoglycans to potentiate WNT signaling.
Dubey R; van Kerkhof P; Jordens I; Malinauskas T; Pusapati GV; McKenna JK; Li D; Carette JE; Ho M; Siebold C; Maurice M; Lebensohn AM; Rohatgi R
Elife; 2020 May; 9():. PubMed ID: 32432544
[TBL] [Abstract][Full Text] [Related]
9. R-spondins: Multi-mode WNT signaling regulators in adult stem cells.
Raslan AA; Yoon JK
Int J Biochem Cell Biol; 2019 Jan; 106():26-34. PubMed ID: 30439551
[TBL] [Abstract][Full Text] [Related]
10. The R-spondin/Lgr5/Rnf43 module: regulator of Wnt signal strength.
de Lau W; Peng WC; Gros P; Clevers H
Genes Dev; 2014 Feb; 28(4):305-16. PubMed ID: 24532711
[TBL] [Abstract][Full Text] [Related]
11. RSPO-LGR4 functions via IQGAP1 to potentiate Wnt signaling.
Carmon KS; Gong X; Yi J; Thomas A; Liu Q
Proc Natl Acad Sci U S A; 2014 Apr; 111(13):E1221-9. PubMed ID: 24639526
[TBL] [Abstract][Full Text] [Related]
12. R-spondin3 Is Associated with Basal-Progenitor Behavior in Normal and Tumor Mammary Cells.
Tocci JM; Felcher CM; García Solá ME; Goddio MV; Zimberlin MN; Rubinstein N; Srebrow A; Coso OA; Abba MC; Meiss RP; Kordon EC
Cancer Res; 2018 Aug; 78(16):4497-4511. PubMed ID: 29748375
[TBL] [Abstract][Full Text] [Related]
13. WNT Signaling Driven by R-spondin 1 and LGR6 in High-grade Serous Ovarian Cancer.
Lee S; Jun J; Kim WJ; Tamayo P; Howell SB
Anticancer Res; 2020 Nov; 40(11):6017-6028. PubMed ID: 33109540
[TBL] [Abstract][Full Text] [Related]
14. The role of R-spondin proteins in cancer biology.
Ter Steege EJ; Bakker ERM
Oncogene; 2021 Nov; 40(47):6469-6478. PubMed ID: 34663878
[TBL] [Abstract][Full Text] [Related]
15. The RSPO-LGR4/5-ZNRF3/RNF43 module in liver homeostasis, regeneration, and disease.
Annunziato S; Sun T; Tchorz JS
Hepatology; 2022 Sep; 76(3):888-899. PubMed ID: 35006616
[TBL] [Abstract][Full Text] [Related]
16. Structural and molecular basis of ZNRF3/RNF43 transmembrane ubiquitin ligase inhibition by the Wnt agonist R-spondin.
Zebisch M; Xu Y; Krastev C; MacDonald BT; Chen M; Gilbert RJ; He X; Jones EY
Nat Commun; 2013; 4():2787. PubMed ID: 24225776
[TBL] [Abstract][Full Text] [Related]
17. LGR4 and LGR5 form distinct homodimers that only LGR4 complexes with RNF43/ZNRF3 to provide high affinity binding of R-spondin ligands.
Toh Y; Wu L; Park S; Wang A; Tu J; Yu W; Zuo M; Carmon KS; Liu QJ
Sci Rep; 2023 Jul; 13(1):10796. PubMed ID: 37402772
[TBL] [Abstract][Full Text] [Related]
18. Clinical value of R-spondins in triple-negative and metaplastic breast cancers.
Coussy F; Lallemand F; Vacher S; Schnitzler A; Chemlali W; Caly M; Nicolas A; Richon S; Meseure D; El Botty R; De-Plater L; Fuhrmann L; Dubois T; Roman-Roman S; Dangles-Marie V; Marangoni E; Bièche I
Br J Cancer; 2017 Jun; 116(12):1595-1603. PubMed ID: 28472820
[TBL] [Abstract][Full Text] [Related]
19. R-spondin-3 is an oncogenic driver of poorly differentiated invasive breast cancer.
Ter Steege EJ; Boer M; Timmer NC; Ammerlaan CM; Song JY; Derksen PW; Hilkens J; Bakker ER
J Pathol; 2022 Nov; 258(3):289-299. PubMed ID: 36106661
[TBL] [Abstract][Full Text] [Related]
20. The structural basis of R-spondin recognition by LGR5 and RNF43.
Chen PH; Chen X; Lin Z; Fang D; He X
Genes Dev; 2013 Jun; 27(12):1345-50. PubMed ID: 23756651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
